Global Gastrointestinal Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 109
Published Date: 25 Jul 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Gastrointestinal Drugs market size was valued at USD 35710 million in 2022 and is forecast to a readjusted size of USD 44110 million by 2029 with a CAGR of 3.1% during review period.
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Gastrointestinal Drugs industry chain, the market status of Chronic Gastritis (Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), Functional Dyspepsia (Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal Drugs.
Regionally, the report analyzes the Gastrointestinal Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal Drugs market.
Regional Analysis: The report involves examining the Gastrointestinal Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal Drugs:
Company Analysis: Report covers individual Gastrointestinal Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Chronic Gastritis, Functional Dyspepsia).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal Drugs. It assesses the current state, advancements, and potential future developments in Gastrointestinal Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other
Major players covered
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal Drugs, with price, sales, revenue and global market share of Gastrointestinal Drugs from 2018 to 2023.
Chapter 3, the Gastrointestinal Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal Drugs.
Chapter 14 and 15, to describe Gastrointestinal Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Gastrointestinal Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gastrointestinal Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prescription Gastrointestinal Drug
1.3.3 OTC Gastrointestinal Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Gastrointestinal Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Chronic Gastritis
1.4.3 Functional Dyspepsia
1.4.4 Peptic Ulcer
1.4.5 Acute Gastroenteritis
1.4.6 Other
1.5 Global Gastrointestinal Drugs Market Size & Forecast
1.5.1 Global Gastrointestinal Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Gastrointestinal Drugs Sales Quantity (2018-2029)
1.5.3 Global Gastrointestinal Drugs Average Price (2018-2029)
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Gastrointestinal Drugs Product and Services
2.1.4 AstraZeneca Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Gastrointestinal Drugs Product and Services
2.2.4 Sanofi Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Gastrointestinal Drugs Product and Services
2.3.4 Bayer Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bayer Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Gastrointestinal Drugs Product and Services
2.4.4 Pfizer Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Gastrointestinal Drugs Product and Services
2.5.4 GlaxoSmithKline Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Gastrointestinal Drugs Product and Services
2.6.4 Teva Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Recent Developments/Updates
2.7 Zeria (Tillotts)
2.7.1 Zeria (Tillotts) Details
2.7.2 Zeria (Tillotts) Major Business
2.7.3 Zeria (Tillotts) Gastrointestinal Drugs Product and Services
2.7.4 Zeria (Tillotts) Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zeria (Tillotts) Recent Developments/Updates
2.8 Perrigo
2.8.1 Perrigo Details
2.8.2 Perrigo Major Business
2.8.3 Perrigo Gastrointestinal Drugs Product and Services
2.8.4 Perrigo Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Perrigo Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business
2.9.3 Boehringer Ingelheim Gastrointestinal Drugs Product and Services
2.9.4 Boehringer Ingelheim Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Boehringer Ingelheim Recent Developments/Updates
2.10 Purdue Pharma
2.10.1 Purdue Pharma Details
2.10.2 Purdue Pharma Major Business
2.10.3 Purdue Pharma Gastrointestinal Drugs Product and Services
2.10.4 Purdue Pharma Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Purdue Pharma Recent Developments/Updates
2.11 C.B. Fleet
2.11.1 C.B. Fleet Details
2.11.2 C.B. Fleet Major Business
2.11.3 C.B. Fleet Gastrointestinal Drugs Product and Services
2.11.4 C.B. Fleet Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 C.B. Fleet Recent Developments/Updates
2.12 Abbott
2.12.1 Abbott Details
2.12.2 Abbott Major Business
2.12.3 Abbott Gastrointestinal Drugs Product and Services
2.12.4 Abbott Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Abbott Recent Developments/Updates
2.13 Jiangzhong
2.13.1 Jiangzhong Details
2.13.2 Jiangzhong Major Business
2.13.3 Jiangzhong Gastrointestinal Drugs Product and Services
2.13.4 Jiangzhong Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangzhong Recent Developments/Updates
2.14 Xian-Janssen
2.14.1 Xian-Janssen Details
2.14.2 Xian-Janssen Major Business
2.14.3 Xian-Janssen Gastrointestinal Drugs Product and Services
2.14.4 Xian-Janssen Gastrointestinal Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Xian-Janssen Recent Developments/Updates
3.1 Global Gastrointestinal Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Gastrointestinal Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Gastrointestinal Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Gastrointestinal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Gastrointestinal Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Gastrointestinal Drugs Manufacturer Market Share in 2022
3.5 Gastrointestinal Drugs Market: Overall Company Footprint Analysis
3.5.1 Gastrointestinal Drugs Market: Region Footprint
3.5.2 Gastrointestinal Drugs Market: Company Product Type Footprint
3.5.3 Gastrointestinal Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Gastrointestinal Drugs Market Size by Region
4.1.1 Global Gastrointestinal Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Gastrointestinal Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Gastrointestinal Drugs Average Price by Region (2018-2029)
4.2 North America Gastrointestinal Drugs Consumption Value (2018-2029)
4.3 Europe Gastrointestinal Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Gastrointestinal Drugs Consumption Value (2018-2029)
4.5 South America Gastrointestinal Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Gastrointestinal Drugs Consumption Value (2018-2029)
5.1 Global Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
5.2 Global Gastrointestinal Drugs Consumption Value by Type (2018-2029)
5.3 Global Gastrointestinal Drugs Average Price by Type (2018-2029)
6.1 Global Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
6.2 Global Gastrointestinal Drugs Consumption Value by Application (2018-2029)
6.3 Global Gastrointestinal Drugs Average Price by Application (2018-2029)
7.1 North America Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
7.2 North America Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
7.3 North America Gastrointestinal Drugs Market Size by Country
7.3.1 North America Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Gastrointestinal Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Gastrointestinal Drugs Market Size by Country
8.3.1 Europe Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Gastrointestinal Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Gastrointestinal Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
10.2 South America Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
10.3 South America Gastrointestinal Drugs Market Size by Country
10.3.1 South America Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Gastrointestinal Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Gastrointestinal Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Gastrointestinal Drugs Market Drivers
12.2 Gastrointestinal Drugs Market Restraints
12.3 Gastrointestinal Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Gastrointestinal Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gastrointestinal Drugs
13.3 Gastrointestinal Drugs Production Process
13.4 Gastrointestinal Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gastrointestinal Drugs Typical Distributors
14.3 Gastrointestinal Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Gastrointestinal Drugs Product and Services
Table 6. AstraZeneca Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Gastrointestinal Drugs Product and Services
Table 11. Sanofi Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Bayer Basic Information, Manufacturing Base and Competitors
Table 14. Bayer Major Business
Table 15. Bayer Gastrointestinal Drugs Product and Services
Table 16. Bayer Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bayer Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Gastrointestinal Drugs Product and Services
Table 21. Pfizer Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Gastrointestinal Drugs Product and Services
Table 26. GlaxoSmithKline Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. Teva Basic Information, Manufacturing Base and Competitors
Table 29. Teva Major Business
Table 30. Teva Gastrointestinal Drugs Product and Services
Table 31. Teva Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Recent Developments/Updates
Table 33. Zeria (Tillotts) Basic Information, Manufacturing Base and Competitors
Table 34. Zeria (Tillotts) Major Business
Table 35. Zeria (Tillotts) Gastrointestinal Drugs Product and Services
Table 36. Zeria (Tillotts) Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zeria (Tillotts) Recent Developments/Updates
Table 38. Perrigo Basic Information, Manufacturing Base and Competitors
Table 39. Perrigo Major Business
Table 40. Perrigo Gastrointestinal Drugs Product and Services
Table 41. Perrigo Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Perrigo Recent Developments/Updates
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Gastrointestinal Drugs Product and Services
Table 46. Boehringer Ingelheim Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boehringer Ingelheim Recent Developments/Updates
Table 48. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Purdue Pharma Major Business
Table 50. Purdue Pharma Gastrointestinal Drugs Product and Services
Table 51. Purdue Pharma Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Purdue Pharma Recent Developments/Updates
Table 53. C.B. Fleet Basic Information, Manufacturing Base and Competitors
Table 54. C.B. Fleet Major Business
Table 55. C.B. Fleet Gastrointestinal Drugs Product and Services
Table 56. C.B. Fleet Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. C.B. Fleet Recent Developments/Updates
Table 58. Abbott Basic Information, Manufacturing Base and Competitors
Table 59. Abbott Major Business
Table 60. Abbott Gastrointestinal Drugs Product and Services
Table 61. Abbott Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Abbott Recent Developments/Updates
Table 63. Jiangzhong Basic Information, Manufacturing Base and Competitors
Table 64. Jiangzhong Major Business
Table 65. Jiangzhong Gastrointestinal Drugs Product and Services
Table 66. Jiangzhong Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jiangzhong Recent Developments/Updates
Table 68. Xian-Janssen Basic Information, Manufacturing Base and Competitors
Table 69. Xian-Janssen Major Business
Table 70. Xian-Janssen Gastrointestinal Drugs Product and Services
Table 71. Xian-Janssen Gastrointestinal Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Xian-Janssen Recent Developments/Updates
Table 73. Global Gastrointestinal Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Gastrointestinal Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Gastrointestinal Drugs Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 76. Market Position of Manufacturers in Gastrointestinal Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Gastrointestinal Drugs Production Site of Key Manufacturer
Table 78. Gastrointestinal Drugs Market: Company Product Type Footprint
Table 79. Gastrointestinal Drugs Market: Company Product Application Footprint
Table 80. Gastrointestinal Drugs New Market Entrants and Barriers to Market Entry
Table 81. Gastrointestinal Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Gastrointestinal Drugs Average Price by Region (2018-2023) & (USD/Unit)
Table 87. Global Gastrointestinal Drugs Average Price by Region (2024-2029) & (USD/Unit)
Table 88. Global Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Gastrointestinal Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Gastrointestinal Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Gastrointestinal Drugs Average Price by Type (2018-2023) & (USD/Unit)
Table 93. Global Gastrointestinal Drugs Average Price by Type (2024-2029) & (USD/Unit)
Table 94. Global Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Gastrointestinal Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Gastrointestinal Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Gastrointestinal Drugs Average Price by Application (2018-2023) & (USD/Unit)
Table 99. Global Gastrointestinal Drugs Average Price by Application (2024-2029) & (USD/Unit)
Table 100. North America Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Gastrointestinal Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Gastrointestinal Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Gastrointestinal Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Gastrointestinal Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Gastrointestinal Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Gastrointestinal Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Gastrointestinal Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Gastrointestinal Drugs Raw Material
Table 141. Key Manufacturers of Gastrointestinal Drugs Raw Materials
Table 142. Gastrointestinal Drugs Typical Distributors
Table 143. Gastrointestinal Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal Drugs Picture
Figure 2. Global Gastrointestinal Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gastrointestinal Drugs Consumption Value Market Share by Type in 2022
Figure 4. Prescription Gastrointestinal Drug Examples
Figure 5. OTC Gastrointestinal Drug Examples
Figure 6. Global Gastrointestinal Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Gastrointestinal Drugs Consumption Value Market Share by Application in 2022
Figure 8. Chronic Gastritis Examples
Figure 9. Functional Dyspepsia Examples
Figure 10. Peptic Ulcer Examples
Figure 11. Acute Gastroenteritis Examples
Figure 12. Other Examples
Figure 13. Global Gastrointestinal Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Gastrointestinal Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Gastrointestinal Drugs Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Gastrointestinal Drugs Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Gastrointestinal Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Gastrointestinal Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Gastrointestinal Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Gastrointestinal Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Gastrointestinal Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Gastrointestinal Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Gastrointestinal Drugs Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Gastrointestinal Drugs Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Gastrointestinal Drugs Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
Figure 55. China Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Gastrointestinal Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Gastrointestinal Drugs Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Gastrointestinal Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Gastrointestinal Drugs Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Gastrointestinal Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Gastrointestinal Drugs Market Drivers
Figure 76. Gastrointestinal Drugs Market Restraints
Figure 77. Gastrointestinal Drugs Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Gastrointestinal Drugs in 2022
Figure 80. Manufacturing Process Analysis of Gastrointestinal Drugs
Figure 81. Gastrointestinal Drugs Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AstraZeneca Sanofi Bayer Pfizer GlaxoSmithKline Teva Zeria (Tillotts) Perrigo Boehringer Ingelheim Purdue Pharma C.B. Fleet Abbott Jiangzhong Xian-Janssen
Related Reports
25 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
